Market Overview

Benzinga's Top #PreMarket Gainers

Share:
Related ALNY
6 Biotech Stocks Jefferies Says Are Undervalued
Why Is Alnylam (ALNY) Up 31.2% Since the Last Earnings Report?
7 Outperforming Stocks With Rising Prices (GuruFocus)
Related MRK
Ransomware Rears Its Head Again As 150 Countries Hit By New Virus
A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside
US pharma giant Merck breached in massive cyber attack (Fox Business)

Alnylam Pharmaceuticals (NASDAQ: ALNY) shares jumped 35.93% to $90.00 in pre-market trading after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Beam (NYSE: BEAM) shares gained 25.93% to $84.35 in the pre-market after the company agreed to be acquired by Suntory Holdings for $83.50 per share in cash.

NII Holdings (NASDAQ: NIHD) surged 20.81% to $2.70 in the pre-market session after the company and Telefonica signed agreements to provide wholesale voice and data services to Nextel in Brazil and Mexico.

Clovis Oncology (NASDAQ: CLVS) soared 6.99% to $79.15 in the pre-market trading after the company announced 2014 objectives and financial outlook.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (ALNY + BEAM)

View Comments and Join the Discussion!